Westchester Capital Management Inc. Has $7.48 Million Holdings in Zimmer Biomet Holdings Inc (ZBH)

Westchester Capital Management Inc. raised its holdings in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 63,882 shares of the medical equipment provider’s stock after buying an additional 833 shares during the quarter. Zimmer Biomet Holdings comprises 3.2% of Westchester Capital Management Inc.’s investment portfolio, making the stock its 21st largest holding. Westchester Capital Management Inc.’s holdings in Zimmer Biomet Holdings were worth $7,480,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. BlackRock Inc. lifted its stake in shares of Zimmer Biomet Holdings by 4.1% during the second quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock valued at $2,236,657,000 after acquiring an additional 679,080 shares during the period. Vanguard Group Inc. lifted its stake in shares of Zimmer Biomet Holdings by 2.6% during the second quarter. Vanguard Group Inc. now owns 13,380,517 shares of the medical equipment provider’s stock valued at $1,718,057,000 after acquiring an additional 339,106 shares during the period. State Street Corp lifted its stake in shares of Zimmer Biomet Holdings by 2.4% during the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock valued at $1,000,463,000 after acquiring an additional 191,747 shares during the period. Longview Partners Guernsey LTD lifted its stake in shares of Zimmer Biomet Holdings by 4.4% during the second quarter. Longview Partners Guernsey LTD now owns 6,377,711 shares of the medical equipment provider’s stock valued at $818,898,000 after acquiring an additional 269,184 shares during the period. Finally, Northern Trust Corp lifted its stake in shares of Zimmer Biomet Holdings by 20.2% during the second quarter. Northern Trust Corp now owns 4,010,274 shares of the medical equipment provider’s stock valued at $514,919,000 after acquiring an additional 673,079 shares during the period. Institutional investors own 85.44% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Westchester Capital Management Inc. Has $7.48 Million Holdings in Zimmer Biomet Holdings Inc (ZBH)” was first posted by Week Herald and is owned by of Week Herald. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://weekherald.com/2017/11/15/westchester-capital-management-inc-increases-holdings-in-zimmer-biomet-holdings-inc-zbh.html.

Several research firms have weighed in on ZBH. Oppenheimer Holdings, Inc. set a $137.00 target price on Zimmer Biomet Holdings and gave the company a “buy” rating in a research note on Monday, August 14th. Deutsche Bank AG raised Zimmer Biomet Holdings from a “hold” rating to a “buy” rating and set a $128.00 price target on the stock in a research report on Tuesday. Edward Jones raised Zimmer Biomet Holdings from a “hold” rating to a “buy” rating in a research report on Thursday, November 9th. Piper Jaffray Companies lowered Zimmer Biomet Holdings from an “overweight” rating to a “neutral” rating in a research report on Thursday, November 2nd. Finally, Royal Bank Of Canada dropped their price target on Zimmer Biomet Holdings to $125.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 7th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. Zimmer Biomet Holdings has an average rating of “Hold” and an average price target of $133.71.

Zimmer Biomet Holdings Inc (ZBH) opened at $112.21 on Wednesday. The firm has a market capitalization of $22,423.90, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 1.72 and a beta of 1.17. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.88. Zimmer Biomet Holdings Inc has a fifty-two week low of $98.20 and a fifty-two week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. Zimmer Biomet Holdings’s revenue was down .8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.79 earnings per share. equities research analysts anticipate that Zimmer Biomet Holdings Inc will post 8.03 earnings per share for the current fiscal year.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply